IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

MARFELLA, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 195
NA - Nord America 164
AF - Africa 97
AS - Asia 93
SA - Sud America 3
Totale 552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 160
RU - Federazione Russa 107
CI - Costa d'Avorio 96
SG - Singapore 79
IE - Irlanda 22
FI - Finlandia 12
CZ - Repubblica Ceca 10
IT - Italia 10
ES - Italia 8
UA - Ucraina 8
CN - Cina 7
DE - Germania 5
GB - Regno Unito 4
CA - Canada 2
PE - Perù 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BE - Belgio 1
BZ - Belize 1
DK - Danimarca 1
EG - Egitto 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MY - Malesia 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
SE - Svezia 1
TM - Turkmenistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 552
Salva come PNG Salva come JPEG
Città #
Abidjan 96
Singapore 59
Boardman 26
Dublin 22
Dallas 18
Jacksonville 10
Brno 8
New York 8
Chandler 7
Helsinki 7
Moscow 7
Córdoba 5
Lappeenranta 5
Los Angeles 5
London 3
Wilmington 3
Bari 2
Frankfurt am Main 2
Huelva 2
Lima 2
Lisbon 2
Molise 2
Munich 2
Princeton 2
Rome 2
San Mateo 2
West Jordan 2
Amsterdam 1
Ashgabat 1
Brussels 1
Buenos Aires 1
Cairo 1
Casavatore 1
Copenhagen 1
Dubai 1
Fort Worth 1
Huntsville 1
Jinan 1
Kunming 1
Lanzhou 1
Milan 1
Murcia 1
Norwalk 1
Olomouc 1
Ottawa 1
Prague 1
Prineville 1
Riga 1
San Francisco 1
Shenzhen 1
Taipei 1
Tashkent 1
Toronto 1
Vientiane 1
Washington 1
Yerevan 1
Totale 340
Salva come PNG Salva come JPEG
Nome #
ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial 59
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 44
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 21
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 20
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 19
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 18
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 16
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19 15
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 14
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 13
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 13
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 13
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 12
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 12
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 12
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 12
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 12
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 12
Advances in Nanomedicine for Precision Insulin Delivery 12
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 11
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 11
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 11
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 10
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 10
Cardiovascular benefits from gliflozins: Effects on endothelial function 10
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients 10
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 10
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 9
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 8
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 8
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 8
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 7
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 7
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 7
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up 7
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 6
Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia 6
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 6
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 6
Metformin Lactic Acidosis: should we still be afraid? 6
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 5
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 5
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 5
Metformin: An old drug against old age and associated morbidities 5
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 5
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 5
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 5
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 4
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 4
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review 4
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 3
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 2
Totale 575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 1 0 1 0 1 0 0 1
2020/202113 0 1 1 2 4 0 2 0 1 0 2 0
2021/202210 0 2 0 0 0 0 2 1 1 2 0 2
2022/202347 5 1 0 3 2 2 0 3 25 1 5 0
2023/202493 3 2 2 2 4 15 3 7 1 5 5 44
2024/2025398 130 48 95 11 114 0 0 0 0 0 0 0
Totale 575